{"url_path":"/sec/tnon/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 UNREGISTERED SALES OF EQUITY","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1560293/0001213900-26-057695-index.html","accession_number":"0001213900-26-057695","cik":"0001560293","ticker":"TNON","issuer_name":"Tenon Medical, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1560293/0001213900-26-057695-index.html","primary_entity_key":"0001560293","primary_entity_name":"Tenon Medical, Inc."},"word_count":74,"has_tables":true,"body_markdown":"ITEM 2. UNREGISTERED SALES OF EQUITY\nSECURITIES AND USE OF PROCEEDS\n\n* *\n\n*(A) Unregistered Sales of Equity Securities*\n\n \n\nExcept for the issuances of unregistered securities\ndescribed in the Current Reports on Form 8-K filed by the Company with the SEC in the first quarter of 2026, the Company did not issue\nany equity securities which were not registered under the Securities Act.\n\n* *\n\n*(B) Use of Proceeds*\n\n \n\nNot applicable.\n\n* *\n\n*(C) Issuer Purchases of Equity Securities*\n\n \n\nNone."}